FOSSAMART-150 – Advanced Bone Health & Osteoporosis Management
FOSSAMART-150 is a prescription medicine containing Ibandronic Acid 150mg, a bisphosphonate used for the treatment and prevention of osteoporosis, particularly in postmenopausal women at increased risk of fractures. It works by slowing bone loss, increasing bone strength, and improving bone mineral density (BMD), helping maintain healthy bones and reduce the risk of fractures.
Osteoporosis is a condition that causes bones to become weak and brittle, making them more susceptible to fractures. FOSSAMART-150 helps preserve bone structure by reducing excessive bone resorption, allowing the body to maintain stronger and healthier bones over time.
Key Benefits of FOSSAMART-150
- Contains Ibandronic Acid 150mg
- Helps treat and prevent osteoporosis
- Increases bone mineral density (BMD)
- Reduces the risk of vertebral fractures
- Helps strengthen weak and fragile bones
- Slows bone loss in postmenopausal women
- Convenient once-monthly oral tablet
- Supports long-term bone health and mobility
Uses of FOSSAMART-150
FOSSAMART-150 is commonly prescribed for:
- Postmenopausal osteoporosis
- Prevention of osteoporosis-related fractures
- Improvement of bone mineral density
- Long-term bone health management
- Patients at high risk of bone fractures as advised by a physician
Why Choose FOSSAMART-150?
FOSSAMART-150 is a clinically proven osteoporosis treatment trusted by healthcare professionals for improving bone strength and reducing fracture risk. Its once-monthly dosing offers convenience, encouraging better treatment adherence while supporting long-term skeletal health.
Important Safety Information
- Prescription-only medicine.
- Use only under the supervision of a qualified healthcare professional.
- Inform your doctor if you have kidney disease, low calcium levels, swallowing difficulties, or esophageal disorders.
- Adequate calcium and Vitamin D intake may be recommended during treatment.
- Maintain good oral hygiene and inform your dentist before dental procedures, as bisphosphonates have been associated with rare jaw-related complications.
- Do not exceed the recommended dose.
- Keep out of reach of children.






Reviews
There are no reviews yet.